Usted está aquí

compartir en google+ compartir en facebook Compartir en Twitter compartir en Linkedin

Grupo de Trabajo Riesgo Vascular

Grupo Riesgo Vascular

Publicaciones FRENA: artículos originales

  1. Monreal M, Álvarez L, Vilaseca B, Coll R, Suárez C, Toril J, Sanclemente C and the FRENA Investigators. Clinical outcome in patients with peripheral artery disease. Results from a prospective Registry (FRENA). Eur J Intern Med 2008 May; 19 (3): 192-7. doi: 10.1016/j.ejim.2007.09.003.
  2. López-Jiménez L, Camafort M, Tiberio G, Carmona JA, Guijarro C, Martínez-Peñalver F, Monreal M, and the FRENA Investigators. Secondary prevention of arterial disease in very elderly people. Results from a Prospective Registry (FRENA). Angiology 2008 Aug-Sep; 59(4): 427-34. doi: 10.1177/0003319707309299.
  3. Barba R, Bisbe J, Alcalá-Pedrajas JN, Toril J, Monte R, Sánchez Muñoz-Torrero JF, Monreal M and the FRENA Investigators. Body mass index and outcome in patients with coronary, cerebrovascular or peripheral artery disease: findings from the FRENA Registry. Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):457-63. doi: 10.1097/HJR.0b013e32832b1818.
  4. Sanclemente C, Suárez C, Escudero D, Piedecausa M, Romero JM, Ceballos A, Gadelha T, Monreal M and the FRENA Investigators. Gender and Outcome in Patients with Coronary, Cerebrovascular or Peripheral Artery Disease. Findings from the FRENA Registry. The Open Atherosclerosis & Thrombosis Journal. 2009, 2: 45-50.
  5. Gadelha T, Bisbe J, Toril J, Alcalá Pedrajas JN, Monreal M and the FRENA Investigators. Major bleeding events in stable outpatients with coronary, cerebrovascular or peripheral artery disease: findings from the FRENA Registry. J Thromb Haemost. 2009 Aug;7(8):1414-6. doi: 10.1111/j.1538-7836.2009.03487.x.
  6. Suriñach JM, Álvarez LR, Coll R, Carmona JA, Sanclemente C, Aguilar E, Monreal M and the FRENA Investigators. Differences in cardiovascular mortality in smokers, past-smokers and non-smoker. Findings from the FRENA Registry. Eur J Internal Med. 2009 Sep;20(5):522-6. doi: 10.1016/j.ejim.2009.05.007.
  7. Roa L, Monreal M, Carmona JA, Aguilar E, Coll R, Suárez C; en representación del Grupo FRENA.Treatment inertia in secondary prevention of cardiovascular disease. Frena Registry. Med Clin (Barc). 2010 Jan 30;134(2):57-63.  doi: 10.1016/j.medcli.2009.07.049.
  8. Esteban C, Pérez P, Fernández-Llamazares J, Suriñach JM, Camafort M, Martorell A, Monreal M, and the FRENA Investigators. Clinical Outcome in Patients With Peripheral Artery Disease and Renal Artery Stenosis. Angiology. 2010 Feb-Mar; 61(1):58-65. doi: 10.1177/0003319708329336.
  9. Sánchez Muñoz-Torrero JF, Escudero D, Suárez C, Sanclemente C, Pascual MT, Zamorano J, Trujillo-Santos J, Monreal M. Concomitant use of proton-pump inhibitors and clopidogrel in patients with coronary, cerebrovascular or peripheral artery disease in the FRENA Registry. J Cardiovasc Pharmacol. 2011 Jan;57(1):13-9. doi: 10.1097/FJC.0b013e3181fc65e5.
  10. Camafort M, Álvarez LR, Sánchez Muñoz-Torrero JF, Sahuquillo JC, López-Jiménez L, Coll R, Monreal M, and the FRENA Investigators. Glucose control and outcome in stable diabetic patients with previous coronary, cerebrovascular or peripheral artery disease. Findings from the FRENA Registry. Diabetic Medicine, 2011 Jan;28(1):73-80. doi: 10.1111/j.1464-5491.2010.03153.x.
  11. García-Diaz AM, Marchena PJ, Toril J, Arnedo G, Sánchez Muñoz-Torrero JF, Yeste M, Aguilar E, Monreal M, and the FRENA Investigators. Alcohol consumption and outcome in stable outpatients with peripheral artery disease. J Vasc Surg. 2011 Oct;54(4):1081-7. doi: 10.1016/j.jvs.2011.03.285.
  12. Aguilar E, García-Díaz AM, Sánchez Muñoz-Torrero JF, Álvarez LR, Piedecausa M, Arnedo G, Monreal M, and the FRENA Investigators. Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation. Thromb Res. 2012 Sep;130(3):390-5.
  13. Sanclemente C, Yeste M, Suárez C, Coll R, Aguilar E, Sahuquillo JC, Lerma Rosa, Monreal M, and the FRENA Investigators. Predictors of outcome in stable outpatients with peripheral artery disease. Intern Emerg Med 2012 Sep 29. doi 10.1007/s11739-012-0854-1.
  14. Álvarez LR, Balibrea JM, Suriñach JM, Coll R, Pascual MT, Toril J, López-Jiménez L, Monreal M, and the FRENA Investigators. Smoking cessation and outcome in stable outpatients with coronary, cerebrovascular or peripheral artery disease. Eur J Prev Cardiol. 2013 Jun;20(3):486-95. doi: 10.1177/1741826711426090.
  15. Bernaudo D, Coll R, Sanchez Muñoz-Torrero JF, Pascual MT, García-Díaz AM, Álvarez LR, Monreal M. and the FRENA Investigators. Renal function and short-term outcome in stable outpatients with coronary, cerebrovascular or peripheral artery disease. Atherosclerosis. 2013 Jul;229(1):258-62. doi: 10.1016/j.atherosclerosis.2013.04.029.
  16. Coll-Fernández R, Coll R, Pascual T, Sánchez Muñoz-Torrero JF, Sahuquillo JC, Manzano Espinosa L, Aguilar E, Alcala-Pedrajas JN, Álvarez LR, García-Díaz AM, Mujal A, Yeste M, Monreal M. Cardiac rehabilitation and outcome in stable outpatients with recent myocardial infarction. Arch Phys Med Rehabil. 2014 Feb; 95 (2) :322-9. doi: 10.1016/j.apmr.2013.09.020
  17. Pérez P, Esteban C, Sahuquillo JC, Yeste M, Manzano L, Mujal A, Jiménez Caballero PE, Aguilar E, Sánchez Muñoz-Torrero JF, Monreal M, and the FRENA Investigators. Cilostazol and outcome in outpatients with peripheral artery disease. Thromb Res. 2014 Aug;134(2):331-5. doi: 10.1016/j.thromres.2014.05.040.